USE OF THE OPIOID ANTAGONIST NALTREXONE TO PREVENT AND CONTROL SIDE EFFECTS CAUSED BY OPIOIDS - Patent 1395260

(19)

(11)

EP 1 395 260 A1

(12)

(43)	Date of publication:
	10.03.2004 Bulletin 2004/11

(21)	Application number: 02726358.1

(22)	Date of filing: 02.05.2002

(51)	International Patent Classification (IPC)⁷: A61K 31/485, A61P 25/04, A61K 9/16, A61K 9/48

(86)	International application number:
	PCT/IB2002/001473

(87)	International publication number:
	WO 2002/087582 (07.11.2002 Gazette 2002/45)

(84)	Designated Contracting States:
	AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
	Designated Extension States:
	AL LT LV MK RO SI

(30)

Priority:

02.05.2001 IT MI20010907

(71)	Applicant: Valpharma S.A.
	47899 Serravalle (SM)

(72)	Inventors:
	VALDUCCI, Roberto I-47039 Savignano Sul Rubicone-Forli' (IT) ALIGHIERI, Tiziano I-47900 Rimini (IT) AVANESSIAN, Serozh I-47900 Rimini (IT) RAFFAELI, William I-47900 Rimini (IT)

(74)	Representative: Negrini, Elena
	Agazzani & Associati S.r.l. & Studio Ing. Giampaolo Agazzani,Via dell'Angelo Custode 11/6 40141 Bologna 40141 Bologna (IT)

(54)	USE OF THE OPIOID ANTAGONIST NALTREXONE TO PREVENT AND CONTROL SIDE EFFECTS CAUSED BY OPIOIDS